Results from the dual Phase III TRIUMpH trials demonstrated the statistical superiority of tegoprazan over lansoprazole in ...

CMS’ draft guidance on real-world data study protocols marks a significant move toward transparency and rigor in Medicare ...

In the Phase III ARISE trial, Cobenfy administered as an adjunctive treatment to atypical antipsychotics for patients with ...

What effect will the tariffs have on drug pricing and patient access? Arda Ural: Over the last 20 years, our industry has taken advantage of the global, integrated economy. The vast majority of global ...

Results from the Phase IIb SunRISe-1 study demonstrated a one-year duration of response with the TAR-200 intravesical ...

With combined investments exceeding $53 billion, both companies are deepening their US presence through expanded biologics ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses the expansion of its ViraxImmune platform into areas such as transplant monitoring, vaccine efficacy, latent virus reactivation, and ...

Lynlee Brown discusses the decisions that companies must make to adjust to the tariffs while also ensuring the ongoing innovation continues.

Where AI and brand translation comes in is the ability of AI to translate across disciplines. Administrative overhead increases on the amount of resources it takes to run any sort of organization. You ...

Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial Success ...

Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial Success ...

Oncology Brands Face Uniquely Complex Market Access Challenges: A Specialized Approach for Commercial Success ...